Share
New Zealand
Select your country/language
New Zealand
Australia
Deutschland (Germany)
France – Français
Italia
Japan - 日本
Norge (Norway)
Poland
Portugal
South Africa
Spain
Suomi (Finland)
Sweden
United Kingdom
United States
Menu
Products
Contact Us
Minimally Invasive Therapies
Products
Cerebral/Somatic Oximetry
INVOS™ Perspective
Patient Outcomes
INVOS™ Perspective
Patient Outcomes
Resources
Patient Outcomes
Make the informed choice for better patient outcomes
Here's why:
The INVOS™ system is the clinical standard.
([FOOTNOTE=Tomlin et al. Detection of critical cerebral desaturation thresholds by three regional oximeters during hypoxia: a pilot study in healthy volunteers. BMC Anesthesiology 2017, 17:6.],[ANCHOR=],[LINK=])
,
([FOOTNOTE=Borg U, A faster and deeper response to hypoxia. White paper 2018.],[ANCHOR=],[LINK=])
All NIRS Technology is not the same.
The INVOS™ system offers a measure of rSO
2
not available with other oximeters.
Get the "absolute" facts.
Customised care for each patient's "normal" is critical.
NIRS Technology
The Only NIRS Technology with Improved Patient Outcomes Labeling
The only cerebral oximeter on the market to be tested and validated under varying levels of CO
2
.
Documented clinical performance.
Clinical studies using the INVOS™ system demonstrate decreased occurrence of postoperative complications and improved outcomes.
([FOOTNOTE=Murkin JM, Adams SJ, Novick RJ, et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007;104(1):51-58.],[ANCHOR=],[LINK=])
,
([FOOTNOTE=Goldman S, Sutter F, Ferdinand F, Trace C. Optimizing intraoperative cerebral oxygen delivery using noninvasive cerebral oximetry decreases the incidence of stroke for cardiac surgical patients. Heart Surg Forum. 2004;7(5):E376-381.],[ANCHOR=],[LINK=])
INVOS™ RESOURCES
View supporting studies and resources.
Learn More
